Pancreatic Cancer

>

Latest News

The safety profile of telisotuzumab adizutecan was manageable in pancreatic ductal adenocarcinoma, consistent with its profile in other tumor types.
Temab-A Displays Early Efficacy in Locally Advanced/Metastatic PDAC

October 20th 2025

The safety profile of telisotuzumab adizutecan was manageable in pancreatic ductal adenocarcinoma, consistent with its profile in other tumor types.

Serious AEs occurred in 49% of patients treated with FOLFIRNOX vs 43% of patients treated with chemoradiation for pancreatic ductal adenocarcinoma.
Neoadjuvant FOLFIRINOX Shows Comparable Survival vs Chemoradiation in PDAC

October 16th 2025

A total of 34 patients were included in the efficacy analysis; all received 320 mg of atebimetinib once daily plus 1000 mg/m2 of gemcitabine and 125 mg/m2 of nab-paclitaxel.
Atebimetinib Plus SOC Chemo Improves Survival/Safety in 1L PDAC

September 25th 2025

analysis of biomarkers associated with outcomes from the trial was presented.3 The biomarker analysis demonstrated that intratumoral myeloid cells and T cells were activated in responding patients.
Mitazalimab/Chemo Yields Promising Survival/Responses in Untreated PDAC

September 22nd 2025

Favorable survival outcomes were identified, overall, in the wild-type and GOF groups vs the non-GOF group.
TP53 Mutations May Reveal Viability of Different Pancreatic Cancer Therapies

September 20th 2025

Video Series
Video Interviews
Podcasts
A nurse practitioner discussed risk factors, diagnostic challenges, and treatment planning in patients with pancreatic cancers.
Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.
Experts from Vanderbilt Medical Center review mechanisms, supporting data, and patient cases associated with the use of IORT in pancreatic cancer.
Diane M. Simeone, MD highlights the importance of multidisciplinary care, surgical practices, and early detection in pancreatic cancer care.
Oncology Peer Review On-The-Go
Latest CME Events & Activities

More News